FDA Inspection 1265389 — Jose Valdez Ramalho Madruga, MD
The FDA completed an inspection of Jose Valdez Ramalho Madruga, MD on March 28, 2025 in Sao Paulo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 28, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sao Paulo (Brazil)
Additional Details
Clinical Investigator (CI)